Balanced news tone
News Sentiment
HBC sentiment intelligence
Hofseth BioCare ASA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
8 relevant articles
Price is moving more forcefully than the current news tone suggests.
72/100 classification confidence.
directly relevant articles
high-authority source matches
-11.0% over one week, -10.6% over four weeks, trend inactive, and below fair value.
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
72/100 classification
One-week reaction
-11.0%
Price reacting lower
Trend fit
Trend inactive
-10.6% over four weeks
Fair value
-43.1%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
7
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 19:01
- Source
- Market source
TipRanks
Direct company coverage
Hofseth BioCare Calls 2026 AGM as Upcycled Salmon Health Business Expands
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- TipRanks
Market source
Direct company coverage
Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 21 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Apr 2026 07:00
- Source
- Market source
NTB Kommunikasjon
Direct company coverage
Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Sep 2025 07:00
- Source
- NTB Kommunikasjon
GlobeNewswire
Direct company coverage
Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 May 2025 07:00
- Source
- GlobeNewswire
SalmonBusiness
Direct company coverage
Debt-for-equity swap: Hofseth Biocare strikes $13.4 million deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 14 Dec 2023 08:00
- Source
- SalmonBusiness
Global Seafood Alliance
Direct company coverage
Aqua-Spark acquires stake in biotech company Hofseth Biocare
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 04 Nov 2021 07:00
- Source
- Global Seafood Alliance